Luxury psychedelic retreats marketed to high achievers. Psilocybin produces measurable brain network changes, but what happens when ego death becomes a premium product?
The rise and fall of scaled psychedelic retreats—branding, influencer marketing, and allegations of unsafe practices. Can you franchise ego death?
The Dreamachine and consumer "psychedelic light" products. Visual flicker reliably evokes hallucinations—but is the market borrowing legitimacy from psychedelic science?
Float tanks minimize sensory input to see what the mind does. Research shows dissolution of body boundaries and altered time perception—natural altered states without substances.
Days in near-total darkness—the visual system generates its own content. Tech elites pay premium prices for experiences that sit between contemplative practice and psychological risk.
Dreams as a design target: detect sleep stage, deliver cues, influence content. MIT's Dormio and targeted memory reactivation are real—now imagine premium "dream concierge" services.
A Nature Neuroscience study on gamma stimulation and lucidity—followed by replication challenges, then productization. The gap between research and consumer claims.
The brain's "self model" is surprisingly plastic. Body transfer illusions, different-race avatars reducing bias—premium retreats could sell curated body-swap experiences.
The Las Vegas Sphere creates VR-like sensations without headsets—presence, vection, multisensory integration for 17,000 people simultaneously. Consciousness engineering as spectacle.
EEG complexity metrics from consciousness research are heading to consumer wellness. Who owns "consciousness data"? Does measurement create a new prestige hierarchy?